MX9804052A - Compuestos de mercaptoalquilpeptidilo que tienen un substituyente de imidazol y su uso como inhibidores de metaloproteinasas (mmp) y/o factor de necrosis tumoral (tnf). - Google Patents
Compuestos de mercaptoalquilpeptidilo que tienen un substituyente de imidazol y su uso como inhibidores de metaloproteinasas (mmp) y/o factor de necrosis tumoral (tnf).Info
- Publication number
- MX9804052A MX9804052A MX9804052A MX9804052A MX9804052A MX 9804052 A MX9804052 A MX 9804052A MX 9804052 A MX9804052 A MX 9804052A MX 9804052 A MX9804052 A MX 9804052A MX 9804052 A MX9804052 A MX 9804052A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- necrosis factor
- tumour necrosis
- Prior art date
Links
- 102000018594 Tumour necrosis factor Human genes 0.000 title abstract 2
- 108050007852 Tumour necrosis factor Proteins 0.000 title abstract 2
- 125000002883 imidazolyl group Chemical group 0.000 title abstract 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000003118 aryl group Chemical group 0.000 abstract 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000001072 heteroaryl group Chemical group 0.000 abstract 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000005213 alkyl heteroaryl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 102000005741 Metalloproteases Human genes 0.000 abstract 1
- 108010006035 Metalloproteases Proteins 0.000 abstract 1
- 125000005024 alkenyl aryl group Chemical group 0.000 abstract 1
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001151 peptidyl group Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523828.3A GB9523828D0 (en) | 1995-11-22 | 1995-11-22 | Compounds |
| GBGB9607121.2A GB9607121D0 (en) | 1996-04-04 | 1996-04-04 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9804052A true MX9804052A (es) | 1998-09-30 |
Family
ID=26308152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9804052A MX9804052A (es) | 1995-11-22 | 1998-05-21 | Compuestos de mercaptoalquilpeptidilo que tienen un substituyente de imidazol y su uso como inhibidores de metaloproteinasas (mmp) y/o factor de necrosis tumoral (tnf). |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6048841A (enExample) |
| EP (1) | EP0874842B1 (enExample) |
| JP (1) | JP2000500482A (enExample) |
| KR (1) | KR19990067687A (enExample) |
| CN (1) | CN1072667C (enExample) |
| AT (1) | ATE215946T1 (enExample) |
| AU (1) | AU711907B2 (enExample) |
| BR (1) | BR9611636A (enExample) |
| CA (1) | CA2229438C (enExample) |
| CZ (1) | CZ291337B6 (enExample) |
| DE (1) | DE69620639T2 (enExample) |
| ES (1) | ES2172690T3 (enExample) |
| HU (1) | HUP9904131A3 (enExample) |
| IL (1) | IL123431A (enExample) |
| MX (1) | MX9804052A (enExample) |
| NO (1) | NO982290L (enExample) |
| NZ (1) | NZ322565A (enExample) |
| PL (1) | PL326710A1 (enExample) |
| WO (1) | WO1997019075A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6673927B2 (en) * | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
| US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| RU2201931C2 (ru) | 1996-11-20 | 2003-04-10 | Биомежер Инкорпорэйтед | Ингибиторы фарнезилтрансферазы и способы ингибирования фарнезилтрансферазы |
| CA2408408C (en) | 2000-05-12 | 2013-07-09 | Genzyme Corporation | Modulators of tnf- alpha signaling |
| EP1282614B1 (en) | 2000-05-15 | 2003-11-12 | Darwin Discovery Limited | Hydroxamic acid derivatives |
| SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
| DE60305446T4 (de) * | 2002-01-07 | 2009-07-09 | Eisai R&D Management Co., Ltd. | Desazapurine und deren verwendung |
| SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
| GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
| DE60335652D1 (de) * | 2002-11-21 | 2011-02-17 | Genzyme Corp | Verwendung eines diamidderivats zur verhinderung der chronischen transplantatabstossung |
| AU2003291143A1 (en) * | 2002-11-21 | 2004-06-18 | Genzyme Corporation | Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance |
| US20040259744A1 (en) * | 2003-12-19 | 2004-12-23 | Meidong Yang | Skin and hair cleansers containing sulfur |
| SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
| US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
| SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
| SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
| TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
| PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
| CN120617250A (zh) * | 2025-07-04 | 2025-09-12 | 南京农业大学 | 小分子化合物Nec-1s在制备治疗脑膜炎药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525629A (en) * | 1992-04-07 | 1996-06-11 | British Bio-Technology Limited | Inhibition of cytokine production |
| GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
| GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
| GB9404046D0 (en) * | 1994-03-03 | 1994-04-20 | Smithkline Beecham Corp | Novel compounds |
| JP3787605B2 (ja) * | 1994-10-05 | 2006-06-21 | ダーウィン・ディスカバリー・リミテッド | ペプチジル化合物および金属プロテアーゼのインヒビターとしてのその治療的使用 |
-
1996
- 1996-11-22 DE DE69620639T patent/DE69620639T2/de not_active Expired - Fee Related
- 1996-11-22 US US08/755,071 patent/US6048841A/en not_active Expired - Fee Related
- 1996-11-22 CA CA002229438A patent/CA2229438C/en not_active Expired - Fee Related
- 1996-11-22 CZ CZ19981455A patent/CZ291337B6/cs not_active IP Right Cessation
- 1996-11-22 IL IL12343196A patent/IL123431A/en not_active IP Right Cessation
- 1996-11-22 AT AT96939208T patent/ATE215946T1/de not_active IP Right Cessation
- 1996-11-22 KR KR1019980703717A patent/KR19990067687A/ko not_active Ceased
- 1996-11-22 NZ NZ322565A patent/NZ322565A/xx unknown
- 1996-11-22 EP EP96939208A patent/EP0874842B1/en not_active Expired - Lifetime
- 1996-11-22 PL PL96326710A patent/PL326710A1/xx unknown
- 1996-11-22 JP JP9519522A patent/JP2000500482A/ja not_active Ceased
- 1996-11-22 BR BR9611636-6A patent/BR9611636A/pt unknown
- 1996-11-22 WO PCT/GB1996/002892 patent/WO1997019075A1/en not_active Ceased
- 1996-11-22 HU HU9904131A patent/HUP9904131A3/hu unknown
- 1996-11-22 ES ES96939208T patent/ES2172690T3/es not_active Expired - Lifetime
- 1996-11-22 CN CN96198507A patent/CN1072667C/zh not_active Expired - Fee Related
- 1996-11-22 AU AU76343/96A patent/AU711907B2/en not_active Ceased
-
1998
- 1998-05-20 NO NO982290A patent/NO982290L/no not_active Application Discontinuation
- 1998-05-21 MX MX9804052A patent/MX9804052A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2229438A1 (en) | 1997-05-29 |
| AU711907B2 (en) | 1999-10-21 |
| BR9611636A (pt) | 1999-12-28 |
| IL123431A0 (en) | 1998-09-24 |
| ES2172690T3 (es) | 2002-10-01 |
| CN1072667C (zh) | 2001-10-10 |
| JP2000500482A (ja) | 2000-01-18 |
| IL123431A (en) | 2001-05-20 |
| DE69620639T2 (de) | 2002-10-17 |
| EP0874842A1 (en) | 1998-11-04 |
| CN1202895A (zh) | 1998-12-23 |
| ATE215946T1 (de) | 2002-04-15 |
| HUP9904131A2 (hu) | 2000-06-28 |
| AU7634396A (en) | 1997-06-11 |
| NO982290D0 (no) | 1998-05-20 |
| WO1997019075A1 (en) | 1997-05-29 |
| HUP9904131A3 (en) | 2002-04-29 |
| CZ145598A3 (cs) | 1998-08-12 |
| KR19990067687A (ko) | 1999-08-25 |
| PL326710A1 (en) | 1998-10-26 |
| NO982290L (no) | 1998-05-20 |
| US6048841A (en) | 2000-04-11 |
| CZ291337B6 (cs) | 2003-02-12 |
| DE69620639D1 (de) | 2002-05-16 |
| EP0874842B1 (en) | 2002-04-10 |
| CA2229438C (en) | 2006-01-17 |
| NZ322565A (en) | 1999-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2229438A1 (en) | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) | |
| EP0192060B1 (de) | Heterocyclische Verbindungen | |
| DE69509401D1 (de) | Peptidische verbindungen und deren therapeutische verwendung als metalloproteinase-inhibitoren | |
| HUP0003921A2 (hu) | VLA-4 által közvetített leukocitaadhéziót gátló szulfonilezett dipeptidszármazékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| ATE242231T1 (de) | Carbonyl-piperaznyl und piperidinyl derivate zur hemmung farnesyl protein transferase | |
| CA2107105A1 (en) | Heterocyclic-cyclic amine derivatives | |
| AU5875498A (en) | Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclo oxygenase ii | |
| IL108259A0 (en) | Piperazine derivates, their preparation and pharmaceutical compositions containing them | |
| DE69924292D1 (de) | Pyrazol verbindungen und ihre verwendung | |
| MX9800186A (es) | Derivados de azetidinona para el tratamiento de ateroesclerosis. | |
| AU591165B2 (en) | Angiotensin converting enzyme inhibitors | |
| NO324229B1 (no) | 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse | |
| AU2626192A (en) | Novel 17beta-substituted aza-androstane derivatives | |
| DE69509875D1 (de) | Nipecotinsäurederivate als antithrombische verbindungen | |
| DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
| AU2001228486A1 (en) | Method for cleaning off-gas flows | |
| DE59010865D1 (de) | N-substituierte naphthalimide, ihre herstellung und verwendung | |
| ATE158301T1 (de) | 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren | |
| TR200003877T2 (tr) | İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri | |
| BG102429A (en) | Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means | |
| DE68918651D1 (de) | Verwendung von Imidazopyrazolderivaten als analgesische und antiinflammatorische Mittel. | |
| DK0868428T3 (da) | Phosphonsyrederivater med metallopeptidaseinhiberende aktivitet | |
| ATE240313T1 (de) | Tricyclische n-cyanoimine als inhibitoren der farnesyl-protein transferase | |
| ITMI931728A1 (it) | Composti eterociclici ad attivita' cardiovascolare | |
| MX9802679A (es) | Derivados de ditiolan, su preparacion y su efecto terapeutico. |